Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.63 |
| ▸ | RAB9A | P51151 | 7/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.55 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.55 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.53 |
| ▸ | TP53 | P04637 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3882727 | 0.86 | HDAC3 (0.71) | NPC1RAB9AATMPTPN1KMT2A | |
| SCHEMBL4611487 | 0.86 | HDAC3 (0.71) | NPC1RAB9AATMPTPN1KMT2A | |
| SCHEMBL8660366 | 0.85 | NPC1 (0.83) | NPC1RAB9AATMPTPN1PSMD14 | |
| SCHEMBL6263820 | 0.85 | NPC1 (0.83) | NPC1RAB9AATMPTPN1PSMD14 | |
| SCHEMBL13126268 | 0.83 | NPC1 (0.55) | NPC1RAB9AATMKMT2AALDH1A1 | |
| SCHEMBL18019596 | 0.82 | NPC1 (0.69) | NPC1RAB9APTPN1CACNA1BAPBA1 | |
| SCHEMBL1763760 | 0.82 | PLK1 (0.67) | NPC1RAB9AATMKMT2AALDH1A1 | |
| SCHEMBL13127203 | 0.81 | NPC1 (0.65) | NPC1RAB9AKMT2AMEN1LMNA | |
| SCHEMBL5697470 | 0.81 | NR1H4 (0.68) | NPC1RAB9AATMPTPN1KMT2A | |
| SCHEMBL14424704 | 0.80 | NPC1 (0.69) | NPC1RAB9AATMPTPN1PSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8093347-B2 | Structured organic films | XEROX CORPORATION (US) | 2012-01-10 | — | — | US | disclosed |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | VIM, PUF60, EPCAM | NPC1 3913/4885RAB9A 4216/4885ATM 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.